DRL-Header DRL-Header

X

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

Loading...

All Data

Filters Filter
×
FILTER:
filter News Type
    filter Company
      filter Product Type
        filter Deal Size
          filter Upfront Payment

            Active Filter(s):

            Product Type

            Companies

            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

            Lead Product(s): EI-1071

            Therapeutic Area: Neurology Product Name: EI-1071

            Highest Development Status: Phase I Product Type: Small molecule

            Partner/Sponsor/Collaborator: Pangu Capital

            Deal Size: $27.0 million Upfront Cash: Undisclosed

            Deal Type: Series A Financing August 23, 2021

            Details:

            Proceeds will be used to advance phase 1 trials of two pipeline candidates, EI-1071 and EI-001 and take three immuno-oncology assets towards IND applications .